HK Stock MarketDetailed Quotes

QUAM PLUS FIN (00952)

Watchlist
  • 0.139
  • -0.001-0.71%
Trading Apr 27 09:33 CST
861.39MMarket Cap-3.66P/E (TTM)

QUAM PLUS FIN (00952) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
-50.11%206.32M
34.78%187.26M
19.64%413.55M
-62.32%138.94M
1,339.61%345.65M
1,269.72%368.7M
-103.25%-27.88M
-94.65%26.92M
-22.34%857.82M
84.73%502.96M
Operating income
-50.11%206.32M
34.78%187.26M
19.64%413.55M
-62.32%138.94M
1,339.61%345.65M
1,269.72%368.7M
-103.25%-27.88M
-94.65%26.92M
-22.34%857.82M
84.73%502.96M
Operating expenses
Gross profit
Employee expense
1.93%-156.4M
8.48%-74.16M
8.26%-159.48M
0.97%-81.03M
-4.79%-173.83M
8.72%-81.83M
10.90%-165.88M
9.08%-89.64M
27.05%-186.18M
20.31%-98.6M
Depreciation and amortization
16.35%-16.39M
14.01%-8.74M
38.50%-19.59M
47.08%-10.17M
24.04%-31.86M
10.42%-19.21M
8.44%-41.94M
8.88%-21.45M
5.05%-45.81M
-1.92%-23.54M
Revaluation surplus
-309.09%-17.94M
---14.04M
120.37%8.58M
----
---42.12M
----
----
----
----
----
-Changes in the fair value of investment property
-309.09%-17.94M
---14.04M
120.37%8.58M
----
---42.12M
----
----
----
----
----
Impairment and provision
-361.06%-55.47M
-79.40%9.36M
-65.71%21.25M
195.10%45.45M
105.81%61.95M
40.68%-47.79M
58.71%-1.07B
65.63%-80.57M
-593.08%-2.58B
-93.35%-234.44M
-Other impairment is provision
-361.06%-55.47M
-79.40%9.36M
-65.71%21.25M
195.10%45.45M
105.81%61.95M
40.68%-47.79M
58.71%-1.07B
65.63%-80.57M
-593.08%-2.58B
-93.35%-234.44M
Operating interest expense
28.34%-37.54M
13.28%-23.03M
-6.11%-52.39M
1.64%-26.56M
1.95%-49.37M
-10.14%-27M
19.36%-50.36M
26.46%-24.52M
43.14%-62.44M
45.78%-33.34M
Special items of operating profit
48.26%-156.29M
2.74%-74.28M
-3,810.05%-302.07M
1.66%-76.37M
103.52%8.14M
-10.55%-77.66M
-26.93%-231.08M
27.22%-70.26M
10.54%-182.05M
9.99%-96.53M
Operating profit
-159.23%-233.7M
124.36%2.37M
-176.04%-90.15M
-108.45%-9.73M
107.49%118.57M
144.39%115.2M
28.06%-1.58B
-1,671.38%-259.51M
-2,010.83%-2.2B
110.04%16.52M
Share of profits of associates
----
----
3,573.20%24.1M
--21.49M
-24.82%-694K
----
-205.70%-556K
-42.35%-242K
355.34%526K
-431.25%-170K
Share of profit from joint venture company
----
----
----
----
----
----
----
----
182.86%1.55M
-185.94%-428K
Earning before tax
-253.83%-233.7M
-79.84%2.37M
-156.03%-66.05M
-89.79%11.76M
107.44%117.87M
144.35%115.2M
27.97%-1.58B
-1,731.93%-259.76M
-2,044.12%-2.2B
109.70%15.92M
Tax
59.22%-2.98M
125.42%152K
-539.26%-7.32M
84.79%-598K
224.12%1.67M
-127.76%-3.93M
100.84%514K
802.58%14.16M
-522.02%-61.39M
-182.12%-2.02M
After-tax profit from continuing operations
-222.61%-236.69M
-77.40%2.52M
-161.38%-73.37M
-89.97%11.16M
107.55%119.54M
145.31%111.27M
29.94%-1.58B
-1,866.71%-245.59M
-2,289.42%-2.26B
108.60%13.9M
Earning after tax
-222.61%-236.69M
-77.40%2.52M
-161.38%-73.37M
-89.97%11.16M
107.55%119.54M
145.31%111.27M
29.94%-1.58B
-1,866.71%-245.59M
-2,289.42%-2.26B
108.60%13.9M
Profit attributable to shareholders
-222.61%-236.69M
-77.40%2.52M
-161.38%-73.37M
-89.97%11.16M
107.55%119.54M
145.31%111.27M
29.94%-1.58B
-1,866.71%-245.59M
-2,289.42%-2.26B
108.60%13.9M
Dividend per share
----
----
----
----
----
--0.011
----
----
----
----
Basic earnings per share
-225.00%-0.039
-77.78%0.0004
-163.16%-0.012
-90.00%0.0018
107.31%0.019
145.00%0.018
29.73%-0.26
-1,839.13%-0.04
-2,302.38%-0.37
108.75%0.0023
Diluted earnings per share
-225.00%-0.039
-77.78%0.0004
-163.16%-0.012
-90.00%0.0018
107.31%0.019
145.00%0.018
29.73%-0.26
-1,839.13%-0.04
-2,302.38%-0.37
108.75%0.0023
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
KPMG
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover -50.11%206.32M34.78%187.26M19.64%413.55M-62.32%138.94M1,339.61%345.65M1,269.72%368.7M-103.25%-27.88M-94.65%26.92M-22.34%857.82M84.73%502.96M
Operating income -50.11%206.32M34.78%187.26M19.64%413.55M-62.32%138.94M1,339.61%345.65M1,269.72%368.7M-103.25%-27.88M-94.65%26.92M-22.34%857.82M84.73%502.96M
Operating expenses
Gross profit
Employee expense 1.93%-156.4M8.48%-74.16M8.26%-159.48M0.97%-81.03M-4.79%-173.83M8.72%-81.83M10.90%-165.88M9.08%-89.64M27.05%-186.18M20.31%-98.6M
Depreciation and amortization 16.35%-16.39M14.01%-8.74M38.50%-19.59M47.08%-10.17M24.04%-31.86M10.42%-19.21M8.44%-41.94M8.88%-21.45M5.05%-45.81M-1.92%-23.54M
Revaluation surplus -309.09%-17.94M---14.04M120.37%8.58M-------42.12M--------------------
-Changes in the fair value of investment property -309.09%-17.94M---14.04M120.37%8.58M-------42.12M--------------------
Impairment and provision -361.06%-55.47M-79.40%9.36M-65.71%21.25M195.10%45.45M105.81%61.95M40.68%-47.79M58.71%-1.07B65.63%-80.57M-593.08%-2.58B-93.35%-234.44M
-Other impairment is provision -361.06%-55.47M-79.40%9.36M-65.71%21.25M195.10%45.45M105.81%61.95M40.68%-47.79M58.71%-1.07B65.63%-80.57M-593.08%-2.58B-93.35%-234.44M
Operating interest expense 28.34%-37.54M13.28%-23.03M-6.11%-52.39M1.64%-26.56M1.95%-49.37M-10.14%-27M19.36%-50.36M26.46%-24.52M43.14%-62.44M45.78%-33.34M
Special items of operating profit 48.26%-156.29M2.74%-74.28M-3,810.05%-302.07M1.66%-76.37M103.52%8.14M-10.55%-77.66M-26.93%-231.08M27.22%-70.26M10.54%-182.05M9.99%-96.53M
Operating profit -159.23%-233.7M124.36%2.37M-176.04%-90.15M-108.45%-9.73M107.49%118.57M144.39%115.2M28.06%-1.58B-1,671.38%-259.51M-2,010.83%-2.2B110.04%16.52M
Share of profits of associates --------3,573.20%24.1M--21.49M-24.82%-694K-----205.70%-556K-42.35%-242K355.34%526K-431.25%-170K
Share of profit from joint venture company --------------------------------182.86%1.55M-185.94%-428K
Earning before tax -253.83%-233.7M-79.84%2.37M-156.03%-66.05M-89.79%11.76M107.44%117.87M144.35%115.2M27.97%-1.58B-1,731.93%-259.76M-2,044.12%-2.2B109.70%15.92M
Tax 59.22%-2.98M125.42%152K-539.26%-7.32M84.79%-598K224.12%1.67M-127.76%-3.93M100.84%514K802.58%14.16M-522.02%-61.39M-182.12%-2.02M
After-tax profit from continuing operations -222.61%-236.69M-77.40%2.52M-161.38%-73.37M-89.97%11.16M107.55%119.54M145.31%111.27M29.94%-1.58B-1,866.71%-245.59M-2,289.42%-2.26B108.60%13.9M
Earning after tax -222.61%-236.69M-77.40%2.52M-161.38%-73.37M-89.97%11.16M107.55%119.54M145.31%111.27M29.94%-1.58B-1,866.71%-245.59M-2,289.42%-2.26B108.60%13.9M
Profit attributable to shareholders -222.61%-236.69M-77.40%2.52M-161.38%-73.37M-89.97%11.16M107.55%119.54M145.31%111.27M29.94%-1.58B-1,866.71%-245.59M-2,289.42%-2.26B108.60%13.9M
Dividend per share ----------------------0.011----------------
Basic earnings per share -225.00%-0.039-77.78%0.0004-163.16%-0.012-90.00%0.0018107.31%0.019145.00%0.01829.73%-0.26-1,839.13%-0.04-2,302.38%-0.37108.75%0.0023
Diluted earnings per share -225.00%-0.039-77.78%0.0004-163.16%-0.012-90.00%0.0018107.31%0.019145.00%0.01829.73%-0.26-1,839.13%-0.04-2,302.38%-0.37108.75%0.0023
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion------
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--KPMG--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More